Insiders Mankind Pharma Limited

Equities

Market Closed - NSE India S.E. Other stock markets 12:05:09 21/05/2026 BST			5-day change	1st Jan Change
2,514.10 ^INR	-2.70%		+4.42%	+14.46%

04-23	CARE Ratings Assigns AA+ Rating to Mankind Pharma's Bank Facilities; Shares Up 3%	MT
03-19	Novo Nordisk patent expiry opens door to cheaper weight-loss drugs in India	RE

31/07/25	Mankind Pharma Limited Announces Resignation of Dr. Sanjay Koul, Chief Marketing Officer, Effective August 1, 2025	CI
18/02/25	Mankind Pharma Limited Announces Cessation of Surendra Lunia as Independent Director	CI
08/01/25	Mankind Pharma Limited Announces Executive Changes	CI
03/12/24	Mankind Pharma Limited Approves Appointment of Ashish Mittal as Company Secretary and Compliance Officer	CI
05/11/24	Mankind Pharma Limited Announces Resignation of Pradeep Chugh as Company Secretary, Effective November 30, 2024	CI
16/10/23	Mankind Pharma Names President/HR Chief	MT
16/10/23	Mankind Pharma Limited Approves Appointment of Prateek Dubey as President - Global Chief Human Resource Officer (Being Senior Management Personnel)	CI
02/08/23	Mankind Pharma Limited Announces Re-Designation of Mr. Suresh Raju Penmetsa as Chief Risk Officer	CI
09/05/23	Mankind Pharma Limited Announces the Resignation of Leonard Lee Kim as Non-Executive Director	CI